Indication
Fatal
1 clinical trial
1 product
Clinical trial
Course of Inflammation and Infection Markers in Critically Ill ICU Patients Under Casirivimab- and/or Tocilizumab ApplicationStatus: Completed, Estimated PCD: 2022-04-28
Product
Treated without